首页 > 最新文献

Cardiovascular Innovations and Applications最新文献

英文 中文
A Flexible Magnetic Soft Continuum Robot for Manipulation and Measurement at Microscale 一种用于微尺度操作和测量的柔性磁性软连续体机器人
4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0067
Dan Liu, Xiaoming Liu, Jialong Du, Zhaofeng Zuo, Xiaoqing Tang, Qiang Huang, Tatsuo Arai, Yiran Hu, Han Jin
Magnetic soft continuum robots have received interest in diverse fields, because of their active steering and remote control capabilities. However, a more challenging task is the development of magnetic soft continuum robots for analyzing the mechanical properties of biological tissue during intravascular treatments. Here, we present a force-controlled soft continuum robot with a magnetic end-effector for measurement of biological mechanical properties. The magnetically driven system contains a set of Helmholtz coils and a permanent magnet. The Helmholtz coils produce an oscillating magnetic field for overcoming friction. The permanent magnet is responsible for steering and providing traction for forward motion. The force on the magnetic tip was calibrated with a soft rod with a known elasticity coefficient. Experimental results indicated that the magnetic soft continuum robot successfully achieved manipulation and stiffness measurement of biological embryos. This strategy for mechanical property analysis of biological tissue expands the opportunities for use of soft continuum robots and broadens the field of functionalization for continuum microrobots.
磁性软连续体机器人由于其主动转向和远程控制能力而受到了广泛的关注。然而,一个更具挑战性的任务是开发磁性软连续体机器人,用于分析血管内治疗过程中生物组织的力学特性。在这里,我们提出了一个力控软连续体机器人与磁性末端执行器测量生物力学性能。磁驱动系统包含一组亥姆霍兹线圈和一块永磁体。亥姆霍兹线圈产生振荡磁场以克服摩擦。永磁体负责转向并为向前运动提供牵引力。用已知弹性系数的软杆校准磁尖上的力。实验结果表明,磁性软连续体机器人成功地实现了生物胚胎的操纵和刚度测量。这种生物组织力学性能分析策略为软连续体机器人的使用提供了机会,并拓宽了连续体微型机器人的功能化领域。
{"title":"A Flexible Magnetic Soft Continuum Robot for Manipulation and Measurement at Microscale","authors":"Dan Liu, Xiaoming Liu, Jialong Du, Zhaofeng Zuo, Xiaoqing Tang, Qiang Huang, Tatsuo Arai, Yiran Hu, Han Jin","doi":"10.15212/cvia.2023.0067","DOIUrl":"https://doi.org/10.15212/cvia.2023.0067","url":null,"abstract":"Magnetic soft continuum robots have received interest in diverse fields, because of their active steering and remote control capabilities. However, a more challenging task is the development of magnetic soft continuum robots for analyzing the mechanical properties of biological tissue during intravascular treatments. Here, we present a force-controlled soft continuum robot with a magnetic end-effector for measurement of biological mechanical properties. The magnetically driven system contains a set of Helmholtz coils and a permanent magnet. The Helmholtz coils produce an oscillating magnetic field for overcoming friction. The permanent magnet is responsible for steering and providing traction for forward motion. The force on the magnetic tip was calibrated with a soft rod with a known elasticity coefficient. Experimental results indicated that the magnetic soft continuum robot successfully achieved manipulation and stiffness measurement of biological embryos. This strategy for mechanical property analysis of biological tissue expands the opportunities for use of soft continuum robots and broadens the field of functionalization for continuum microrobots.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136306090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart Failure with Preserved Ejection Fraction: Important Things to Know About the Stiff Heart 保留射血分数的心力衰竭:关于僵硬心脏的重要知识
4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0058
Juan R. Vilaro
{"title":"Heart Failure with Preserved Ejection Fraction: Important Things to Know About the Stiff Heart","authors":"Juan R. Vilaro","doi":"10.15212/cvia.2023.0058","DOIUrl":"https://doi.org/10.15212/cvia.2023.0058","url":null,"abstract":"","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136053933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early is Better Than Late, but Late is Better Than Never: Referral to Advanced Heart Failure Cardiology 早比晚好,但晚总比不好:转介到晚期心力衰竭心脏病学
4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0065
Alex M. Parker, Mustafa M. Ahmed
The advanced heart failure cardiology practice treats a wide spectrum of patients in different stages of heart failure, including those at risk of developing heart failure syndrome; those requiring advanced heart failure therapies such as transplantation or left ventricular assist device (LVAD) placement; and those at the end of life, receiving palliative focused therapies such as inotropes. The timing of referral to advanced heart failure practices has been thoroughly discussed in the cardiology community. However, objective data to guide this timing are limited.
{"title":"Early is Better Than Late, but Late is Better Than Never: Referral to Advanced Heart Failure Cardiology","authors":"Alex M. Parker, Mustafa M. Ahmed","doi":"10.15212/cvia.2023.0065","DOIUrl":"https://doi.org/10.15212/cvia.2023.0065","url":null,"abstract":"The advanced heart failure cardiology practice treats a wide spectrum of patients in different stages of heart failure, including those at risk of developing heart failure syndrome; those requiring advanced heart failure therapies such as transplantation or left ventricular assist device (LVAD) placement; and those at the end of life, receiving palliative focused therapies such as inotropes. The timing of referral to advanced heart failure practices has been thoroughly discussed in the cardiology community. However, objective data to guide this timing are limited.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"36 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136053921","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of the Mathematical Relationship between the Aortic Valve and Aortic Root: Implications for Precise Guidance in Aortic Valve Repair 主动脉瓣与主动脉根部数学关系的研究:对主动脉瓣修复精确指导的意义
IF 0.5 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0044
Luyao Ma, Kangting Tang, Guanyu Yang, Hong Liu, Chengxiao Xu, Yinsu Zhu, Y. Shao
Background: The study was aimed at investigating the mathematical relationship between the aortic valve and aortic root through CTA imaging-based reconstruction. Methods: We selected 121 healthy participants and analyzed the measurements of aortic root dimensions, including the sinotubular junction (SJT), ventriculo-arterial junction (VAJ), maximum sinus diameter (SD), sinus height (SH), effective height (eH) and coaptation height (cH). We also reconstructed 3-D aortic valve cusps using CTA imaging to calculate the aortic cusp surface areas. Data were collected to analyze the ratios and the correlation between aortic valve and aortic root dimensions. Results: Among healthy participants, the STJ was approximately 10% larger than the VAJ, and the SD was 1.375 times larger than the VAJ. The average eH and cH were 8.94 mm and 3.62 mm, respectively. The aortic cusp surface areas were larger in men than women. Regardless of sex, the non-coronary cusp was found to be largest, and was followed by the right coronary cusp and the left coronary cusp. Although the aortic root dimensions were also significantly larger in in men than women, the STJ to VAJ, SD to VAJ, and SH to VAJ ratios did not significantly differ by sex. The mathematical relationship between the aortic cusp surface areas and VAJ orifice area was calculated as aortic cusp surface areas Conclusions: The aortic root has specific geometric ratios. The mathematical relationship between the aortic valve and aortic root might be used to guide aortic valve repair.
背景:本研究旨在通过基于CTA成像的主动脉瓣与主动脉根部重建,探讨主动脉瓣与主动脉根部之间的数学关系。方法:选取121名健康受试者,分析其主动脉根部尺寸测量,包括窦管交界处(SJT)、心室动脉交界处(VAJ)、最大窦径(SD)、窦高(SH)、有效高度(eH)和包合高度(cH)。我们还利用CTA成像重建了三维主动脉瓣尖,计算了主动脉瓣尖表面积。收集数据,分析主动脉瓣与主动脉根尺寸的比值及相关性。结果:在健康参与者中,STJ比VAJ大约10%,SD是VAJ的1.375倍。平均eH和cH分别为8.94 mm和3.62 mm。男性的主动脉尖表面积大于女性。不论性别,非冠状动脉尖最大,其次是右冠状动脉尖和左冠状动脉尖。尽管男性主动脉根部尺寸也明显大于女性,但STJ / VAJ、SD / VAJ和SH / VAJ的比例在性别上没有显著差异。计算主动脉瓣尖表面积与VAJ孔口面积的数学关系为主动脉瓣尖表面积。结论:主动脉根部具有一定的几何比例。主动脉瓣与主动脉根部之间的数学关系可用于指导主动脉瓣修复。
{"title":"Investigation of the Mathematical Relationship between the Aortic Valve and Aortic Root: Implications for Precise Guidance in Aortic Valve Repair","authors":"Luyao Ma, Kangting Tang, Guanyu Yang, Hong Liu, Chengxiao Xu, Yinsu Zhu, Y. Shao","doi":"10.15212/cvia.2023.0044","DOIUrl":"https://doi.org/10.15212/cvia.2023.0044","url":null,"abstract":"Background: The study was aimed at investigating the mathematical relationship between the aortic valve and aortic root through CTA imaging-based reconstruction. Methods: We selected 121 healthy participants and analyzed the measurements of aortic root dimensions, including the sinotubular junction (SJT), ventriculo-arterial junction (VAJ), maximum sinus diameter (SD), sinus height (SH), effective height (eH) and coaptation height (cH). We also reconstructed 3-D aortic valve cusps using CTA imaging to calculate the aortic cusp surface areas. Data were collected to analyze the ratios and the correlation between aortic valve and aortic root dimensions. Results: Among healthy participants, the STJ was approximately 10% larger than the VAJ, and the SD was 1.375 times larger than the VAJ. The average eH and cH were 8.94 mm and 3.62 mm, respectively. The aortic cusp surface areas were larger in men than women. Regardless of sex, the non-coronary cusp was found to be largest, and was followed by the right coronary cusp and the left coronary cusp. Although the aortic root dimensions were also significantly larger in in men than women, the STJ to VAJ, SD to VAJ, and SH to VAJ ratios did not significantly differ by sex. The mathematical relationship between the aortic cusp surface areas and VAJ orifice area was calculated as aortic cusp surface areas Conclusions: The aortic root has specific geometric ratios. The mathematical relationship between the aortic valve and aortic root might be used to guide aortic valve repair.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67306743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex Differences in Transcatheter Structural Heart Disease Interventions: How Much Do We Know? 经导管结构性心脏病干预的性别差异:我们知道多少?
IF 0.5 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0049
L. Ya'qoub, Jelena Z Arnautovic, N. Faza, I. Elgendy
The number of structural heart disease interventions has greatly increased in the past decade. Moreover, interest in the sex-specific outcomes of various cardiovascular conditions and procedures has increased. In this review, we discuss the sex differences in the clinical profiles and outcomes of patients undergoing the most commonly performed structural procedures: transcatheter aortic valve replacement, transcatheter edge to edge repair of the mitral and tricuspid valve, transcatheter pulmonary valve replacement, patent foramen ovale closure and left atrial appendage occlusion. We shed light on potential reasons for these differences and emphasize the importance of increasing the representation of women in randomized clinical trials, to understand these differences and support the application of these cutting-edge technologies.
在过去十年中,结构性心脏病干预的数量大大增加。此外,对各种心血管疾病和手术的性别特异性结果的兴趣有所增加。在这篇综述中,我们讨论了接受最常见的结构性手术的患者的临床概况和结果的性别差异:经导管主动脉瓣置换术、经导管二尖瓣和三尖瓣边缘修复术、经导管肺动脉瓣置换术、卵圆孔未闭闭锁术和左心房附件闭塞术。我们揭示了这些差异的潜在原因,并强调了在随机临床试验中增加女性代表性的重要性,以了解这些差异并支持这些尖端技术的应用。
{"title":"Sex Differences in Transcatheter Structural Heart Disease Interventions: How Much Do We Know?","authors":"L. Ya'qoub, Jelena Z Arnautovic, N. Faza, I. Elgendy","doi":"10.15212/cvia.2023.0049","DOIUrl":"https://doi.org/10.15212/cvia.2023.0049","url":null,"abstract":"The number of structural heart disease interventions has greatly increased in the past decade. Moreover, interest in the sex-specific outcomes of various cardiovascular conditions and procedures has increased. In this review, we discuss the sex differences in the clinical profiles and outcomes of patients undergoing the most commonly performed structural procedures: transcatheter aortic valve replacement, transcatheter edge to edge repair of the mitral and tricuspid valve, transcatheter pulmonary valve replacement, patent foramen ovale closure and left atrial appendage occlusion. We shed light on potential reasons for these differences and emphasize the importance of increasing the representation of women in randomized clinical trials, to understand these differences and support the application of these cutting-edge technologies.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67307223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research Progress in Finerenone in Cardiovascular Diseases 芬烯酮在心血管疾病中的研究进展
4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0060
Sun Xue, Dong Yanghong, Gu Jiaxin, Liu Wenxiu, Liu Yue
Mineralocorticoid receptor antagonists (MRA) have significant therapeutic effects on heart failure, hypertension, chronic kidney disease and primary aldosteronism. However, steroid MRA can cause hyperkalemia, deterioration of renal insufficiency, menstrual disorder and male breast development, and consequently has found limited clinical applications. In recent years, basic and clinical studies have confirmed that finerenone is a new non-steroidal MRA with high receptor affinity and selectivity, which can decrease adverse effects such as hyperkalemia and exert powerful cardioprotective effects. Herein, the structure, function, pharmacological mechanism and adverse effects of finerenone are summarized, and its cardiovascular protective effects and clinical applications are described in detail, to aid in understanding of the roles of finerenone in treating cardiovascular diseases and to explore future directions.
矿盐皮质激素受体拮抗剂(MRA)对心力衰竭、高血压、慢性肾病和原发性醛固酮增多症有显著的治疗作用。然而,类固醇MRA可引起高钾血症、肾功能不全恶化、月经紊乱和男性乳房发育,因此临床应用有限。近年来的基础和临床研究证实,芬烯酮是一种新型的非甾体MRA,具有高受体亲和力和选择性,可以减少高钾血症等不良反应,并发挥强大的心脏保护作用。本文综述了芬尼酮的结构、功能、药理机制和不良反应,并详细介绍了其心血管保护作用和临床应用,以帮助了解芬尼酮在治疗心血管疾病中的作用,并探讨其未来发展方向。
{"title":"Research Progress in Finerenone in Cardiovascular Diseases","authors":"Sun Xue, Dong Yanghong, Gu Jiaxin, Liu Wenxiu, Liu Yue","doi":"10.15212/cvia.2023.0060","DOIUrl":"https://doi.org/10.15212/cvia.2023.0060","url":null,"abstract":"Mineralocorticoid receptor antagonists (MRA) have significant therapeutic effects on heart failure, hypertension, chronic kidney disease and primary aldosteronism. However, steroid MRA can cause hyperkalemia, deterioration of renal insufficiency, menstrual disorder and male breast development, and consequently has found limited clinical applications. In recent years, basic and clinical studies have confirmed that finerenone is a new non-steroidal MRA with high receptor affinity and selectivity, which can decrease adverse effects such as hyperkalemia and exert powerful cardioprotective effects. Herein, the structure, function, pharmacological mechanism and adverse effects of finerenone are summarized, and its cardiovascular protective effects and clinical applications are described in detail, to aid in understanding of the roles of finerenone in treating cardiovascular diseases and to explore future directions.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"40 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136257262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The 34th Great Wall International Congress of Cardiology Asian Heart Society Congress 2023 第34届长城国际心脏病学大会2023年亚洲心脏学会大会
4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0059
{"title":"The 34th Great Wall International Congress of Cardiology Asian Heart Society Congress 2023","authors":"","doi":"10.15212/cvia.2023.0059","DOIUrl":"https://doi.org/10.15212/cvia.2023.0059","url":null,"abstract":"","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135356411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tyrosine Kinase Inhibitor Antitumor Therapy and Atrial Fibrillation: Potential Off-Target Effects on Mitochondrial Function and Cardiac Substrate Utilization 酪氨酸激酶抑制剂抗肿瘤治疗和心房颤动:对线粒体功能和心脏底物利用的潜在脱靶效应
4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0070
Yukun Li, Xiaodong Peng, Rong Lin, Xuesi Wang, Xinmeng Liu, Fanchao Meng, Yanfei Ruan, Rong Bai, Ribo Tang, Nian Liu
Tyrosine kinase inhibitors (TKIs) are a novel category of antitumor agents with remarkable efficacy in extending patient survival. However, clinical use of TKIs has been hindered by the major adverse effect of atrial fibrillation (AF). Recent studies have revealed that TKIs induce metabolic alterations and remodeling in cardiomyocytes, thus perturbing energy metabolism. Specifically, mitochondrial dysfunction and shifts in cardiac substrate utilization have been implicated in the mechanisms underlying TKI-induced AF. In light of these findings, this article reviews the energy metabolism-associated pathways involved in TKI-induced AF, identifies precise therapeutic targets for managing this condition, and discusses evidence that may contribute to the development of novel TKIs without cardiac adverse effects.
酪氨酸激酶抑制剂(TKIs)是一类新型的抗肿瘤药物,在延长患者生存期方面具有显著的疗效。然而,TKIs的临床应用一直受到心房颤动(AF)主要不良反应的阻碍。最近的研究表明,TKIs诱导心肌细胞的代谢改变和重塑,从而扰乱能量代谢。具体来说,线粒体功能障碍和心脏底物利用的变化与tki诱导AF的机制有关。鉴于这些发现,本文回顾了tki诱导AF中涉及的能量代谢相关途径,确定了精确的治疗靶点,并讨论了可能有助于开发无心脏不良反应的新型tki的证据。
{"title":"Tyrosine Kinase Inhibitor Antitumor Therapy and Atrial Fibrillation: Potential Off-Target Effects on Mitochondrial Function and Cardiac Substrate Utilization","authors":"Yukun Li, Xiaodong Peng, Rong Lin, Xuesi Wang, Xinmeng Liu, Fanchao Meng, Yanfei Ruan, Rong Bai, Ribo Tang, Nian Liu","doi":"10.15212/cvia.2023.0070","DOIUrl":"https://doi.org/10.15212/cvia.2023.0070","url":null,"abstract":"Tyrosine kinase inhibitors (TKIs) are a novel category of antitumor agents with remarkable efficacy in extending patient survival. However, clinical use of TKIs has been hindered by the major adverse effect of atrial fibrillation (AF). Recent studies have revealed that TKIs induce metabolic alterations and remodeling in cardiomyocytes, thus perturbing energy metabolism. Specifically, mitochondrial dysfunction and shifts in cardiac substrate utilization have been implicated in the mechanisms underlying TKI-induced AF. In light of these findings, this article reviews the energy metabolism-associated pathways involved in TKI-induced AF, identifies precise therapeutic targets for managing this condition, and discusses evidence that may contribute to the development of novel TKIs without cardiac adverse effects.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135444945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phrenic Nerve Injury During Ablation of Atrial Fibrillation: Mechanisms, Clinical Features, Prognosis, and Prevention Methods 心房颤动消融过程中膈神经损伤:机制、临床特征、预后和预防方法
IF 0.5 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0050
Xinmeng Liu, Rong Lin, Xiaodong Peng, Xuesi Wang, Yukun Li, Fanchao Meng, Y. Ruan, Nian Liu
Atrial fibrillation ablation procedures have become a focus of research among electrophysiologists, with the aim of increasing success rates while minimizing complications. One major concern is phrenic nerve injury (PNI). Despite advancements in ablation strategies, equipment, and monitoring methods, the incidence of PNI during these procedures remains substantial, particularly during cryoballoon ablation, which has a reported PNI incidence of 3.5%. This review examines recent studies, to provide a comprehensive overview of PNI mechanisms, clinical features, prognosis, and methods for prevention during ablation.
心房颤动消融手术已成为电生理学家研究的焦点,目的是提高成功率,同时尽量减少并发症。一个主要问题是膈神经损伤(PNI)。尽管消融策略、设备和监测方法都有了进步,但在这些过程中PNI的发生率仍然很高,特别是在低温球囊消融过程中,据报道PNI发生率为3.5%。本文回顾了最近的研究,提供了PNI机制、临床特征、预后和消融期间预防方法的全面概述。
{"title":"Phrenic Nerve Injury During Ablation of Atrial Fibrillation: Mechanisms, Clinical Features, Prognosis, and Prevention Methods","authors":"Xinmeng Liu, Rong Lin, Xiaodong Peng, Xuesi Wang, Yukun Li, Fanchao Meng, Y. Ruan, Nian Liu","doi":"10.15212/cvia.2023.0050","DOIUrl":"https://doi.org/10.15212/cvia.2023.0050","url":null,"abstract":"Atrial fibrillation ablation procedures have become a focus of research among electrophysiologists, with the aim of increasing success rates while minimizing complications. One major concern is phrenic nerve injury (PNI). Despite advancements in ablation strategies, equipment, and monitoring methods, the incidence of PNI during these procedures remains substantial, particularly during cryoballoon ablation, which has a reported PNI incidence of 3.5%. This review examines recent studies, to provide a comprehensive overview of PNI mechanisms, clinical features, prognosis, and methods for prevention during ablation.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67307278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term Clinical Outcomes of Coronary Rotational Atherectomy for Specific Indications 特定适应症冠脉旋转动脉粥样硬化切除术的长期临床结果
IF 0.5 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 DOI: 10.15212/cvia.2023.0016
Cheng-fu Cao, Wei-li Teng, Yuliang Ma, Qi Li, Hong Zhao, Mingyu Lu, Jian Liu, Wei-min Wang
Objective: This study compared the long-term outcomes between rotational atherectomy (RA) for specific indications and on-label use of RA for severely calcified coronary lesions. Methods: Data for patients who underwent RA between 2015 and 2020 in a single-center registry were analyzed. The specific indication group included patients with ostial lesions, unprotected left main coronary artery stenosis, chronic total occlusions, stent ablation, angulated lesions, and cardiac dysfunction, whereas patients with none of the above-mentioned characteristics were included in the on-label group. The primary endpoint was compared between groups. Results: A total of 176 patients in the on-label group and 125 patients in the specific indication group were included. Patient clinical characteristics were comparable between groups. The incidence of complications during the procedure was higher in the specific indication group than in the on-label group (20.0% vs. 10.8%, P=0.018). No significant difference was observed in in-hospital MACCE between groups (12.5% vs 9.7%, P=0.392). During 35 (10–57) months of follow-up, MACCE occurred in 46 patients (15.3%). The incidence of MACCE was much higher in the specific indication group than the on-label group (25.6% vs 13.6%, P=0.034). Conclusions: RA for specific indications, compared with on-label use, had a higher incidence of complications during the procedure and poorer long-term clinical outcomes.
目的:本研究比较了特定适应症的旋转动脉粥样硬化切除术(RA)和标签上使用RA治疗严重钙化冠状动脉病变的长期结果。方法:对2015年至2020年单中心登记的RA患者数据进行分析。特殊适应症组包括有开口病变、无保护的左主干冠状动脉狭窄、慢性全闭塞、支架消融、成角病变和心功能不全的患者,而未标记组包括没有上述特征的患者。比较两组间的主要终点。结果:标签组176例,特殊适应症组125例。两组患者临床特征具有可比性。特定适应症组手术过程中并发症的发生率高于标签组(20.0%比10.8%,P=0.018)。两组住院MACCE比较差异无统计学意义(12.5% vs 9.7%, P=0.392)。在35(10-57)个月的随访中,46例(15.3%)患者发生MACCE。特定适应症组的MACCE发生率远高于标签组(25.6% vs 13.6%, P=0.034)。结论:与标签上使用的RA相比,用于特定适应症的RA在手术过程中有更高的并发症发生率和较差的长期临床结果。
{"title":"Long-term Clinical Outcomes of Coronary Rotational Atherectomy for Specific Indications","authors":"Cheng-fu Cao, Wei-li Teng, Yuliang Ma, Qi Li, Hong Zhao, Mingyu Lu, Jian Liu, Wei-min Wang","doi":"10.15212/cvia.2023.0016","DOIUrl":"https://doi.org/10.15212/cvia.2023.0016","url":null,"abstract":"Objective: This study compared the long-term outcomes between rotational atherectomy (RA) for specific indications and on-label use of RA for severely calcified coronary lesions. Methods: Data for patients who underwent RA between 2015 and 2020 in a single-center registry were analyzed. The specific indication group included patients with ostial lesions, unprotected left main coronary artery stenosis, chronic total occlusions, stent ablation, angulated lesions, and cardiac dysfunction, whereas patients with none of the above-mentioned characteristics were included in the on-label group. The primary endpoint was compared between groups. Results: A total of 176 patients in the on-label group and 125 patients in the specific indication group were included. Patient clinical characteristics were comparable between groups. The incidence of complications during the procedure was higher in the specific indication group than in the on-label group (20.0% vs. 10.8%, P=0.018). No significant difference was observed in in-hospital MACCE between groups (12.5% vs 9.7%, P=0.392). During 35 (10–57) months of follow-up, MACCE occurred in 46 patients (15.3%). The incidence of MACCE was much higher in the specific indication group than the on-label group (25.6% vs 13.6%, P=0.034). Conclusions: RA for specific indications, compared with on-label use, had a higher incidence of complications during the procedure and poorer long-term clinical outcomes.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"1 1","pages":""},"PeriodicalIF":0.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67306140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cardiovascular Innovations and Applications
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1